-
Common epilepsy medication ineffective for nearly 2 out of 3 patients, Langone researchers find
18 Sep 2025 11:16 GMT
… a commonly prescribed focal epilepsy treatment, levetiracetam, continued to experience seizure symptoms … received the correct dosage of drugs — or in some cases, until … and examined different types of medicine and dosages.
The team found …
-
Management of Antiseizure Medications in Pregnancy
16 Sep 2025 16:58 GMT
… differences may lower antiepileptic drug concentrations, which also increases … medication. Pharmacists can also identify gaps that exist in treatment … Pharmaceuticals, Inc; 2024.
15. Levetiracetam product information. Hauppauge, NY: ScieGen Pharmaceuticals, …
-
Generic medicine Industry join calls for an urgent pause to the extended producer responsibility scheme for urban wastewater, to avert a healthcare crisis.
10 Sep 2025 10:00 GMT
… standards of wastewater treatment under applicable laws … drugs, food additives, industrial chemicals, cosmetics – not just medicines … . The figure is distorted further because pharmaceuticals are … soar by 369%; Levetiracetam, relied upon by …
-
RAP-219 Meets Primary End Point in Phase 2a Trial for Focal-Onset Seizures
09 Sep 2025 19:26 GMT
… remainder of the treatment period. The trial’s primary … medications, with the highest proportion of them on lamotrigine (50%), levetiracetam … treating patients living with drug-resistant focal seizures.”
… into two Phase 3 trials using traditional clinical …
-
Rapport Announces Positive Topline Results from Phase 2a Clinical Trial of RAP-219 in Patients with Focal Onset Seizures
08 Sep 2025 10:00 GMT
… ”), a clinical-stage biotechnology company dedicated to the … in future registrational trials. The trial enrolled 12 women … lamotrigine (50%), levetiracetam (40%), and cenobamate (37%) medications. “We … as a potential treatment for drug-resistant focal onset …
-
Rapport shares double on better-than-expected seizure drug data
08 Sep 2025 18:46 GMT
… medicine that widely beat analyst and investor expectations.
Treatment with Rapport’s drug … two Phase 3 trials in the third … clinically meaningful benchmark.
Trial investigators also measured … medications during the study, typically lamotrigine, levetiracetam …
-
Healthcare Utilization and Cost in the Two Years Before Neuromodulation Implantation Among Medicaid Enrollees with Drug-Resistant Epilepsy
28 Aug 2025 14:13 GMT
… Food and Drug Administration (FDA) for the treatment of epilepsy … medications dispensed (in National Drug Code format), therapy-days and number of pills … prescribed ASM was levetiracetam (prescribed to 55 … patients were dispensed antidepressants, and 10% were …
-
Study: Medications take about a year to get epilepsy under control
26 Aug 2025 15:29 GMT
… relief from anti-seizure medications, New York researchers say … time for doctors to dial in the right drug and … did not respond well to drug treatment, researchers said.
Notably, those … 57% patients initially prescribed levetiracetam became seizure-free on …
-
Antiseizure Medications Show No Significant Impact on Epilepsy Risk After Brain Abscess: JAMA
19 Aug 2025 16:34 GMT
… the treatment of brain abscesses, including whether antiseizure drugs (ASMs … through December of 2024. Levetiracetam, valproate, and phenytoin … Overall, the replicated trial did not find that … 2025). Initiation of antiseizure medications in patients with brain …
-
Active Pharmaceutical Ingredients (API) Market Forecast to Cross US$ 466.9 Bn by 2035 – Transparency Market Research
14 Aug 2025 21:28 GMT
… antidepressants, anti-diabetics, analgesics, anti-inflammatory drugs … • Piperaquine Phosphate Sotalol • Levetiracetam • Diclofenac • Azithromycin • … End User:
Pharmaceutical Companies • Biotechnological Companies • CMOs … -treatment-market.html
Medical and …